Search Results - "Meng, Jianzhou"
-
1
Evaluation of a novel inhibitor of aspartate semialdehyde dehydrogenase as a potent antitubercular agent against Mycobacterium tuberculosis
Published in Journal of antibiotics (01-06-2022)“…The in vitro activity of IMB-XMA0038, a novel inhibitor targeting Mycobacterial tuberculosis ( Mtb ) aspartate semialdehyde dehydrogenase, was evaluated…”
Get full text
Journal Article -
2
Digging Deeper to Save the Old Anti-tuberculosis Target: D-Alanine-D-Alanine Ligase With a Novel Inhibitor, IMB-0283
Published in Frontiers in microbiology (15-01-2020)“…The emergence of drug-resistant (Mtb) has hampered treatments for tuberculosis, which consequently now require novel agents to overcome such drug resistance…”
Get full text
Journal Article -
3
IMB-XMA0038, a new inhibitor targeting aspartate-semialdehyde dehydrogenase of Mycobacterium tuberculosis
Published in Emerging microbes & infections (01-01-2021)“…The emergence of drug-resistant tuberculosis (TB) constitutes a major challenge to TB control programmes. There is an urgent need to develop effective anti-TB…”
Get full text
Journal Article -
4
Identification and Validation of Aspartic Acid Semialdehyde Dehydrogenase as a New Anti-Mycobacterium Tuberculosis Target
Published in International journal of molecular sciences (30-09-2015)“…Aspartic acid semialdehyde dehydrogenase (ASADH) lies at the first branch point in the essential aspartic acid biosynthetic pathway that is found in bacteria…”
Get full text
Journal Article -
5
Plasmid to generate Mycobacteria mutants
Published in AMB Express (01-02-2018)“…The generation of conditional mutants has been an effective approach to studying bacteria and validating drug targets, and mutants of Mycobacteria are no…”
Get full text
Journal Article -
6
JIB-04, an inhibitor of Jumonji histone demethylase as a potent antitubercular agent against Mycobacterium tuberculosis
Published in Archives of microbiology (01-12-2024)“…The increasing drug resistance of Mycobacterium tuberculosis (Mtb), coupled with the limited availability of effective anti-tuberculosis medications, poses…”
Get full text
Journal Article -
7
Long non-coding RNA UCA1 upregulates KIF20A expression to promote cell proliferation and invasion via sponging miR-204 in cervical cancer
Published in Cell cycle (Georgetown, Tex.) (01-10-2020)“…Cervical cancer is a female cancer with the second highest motility over the world. It is urgent to find new therapeutic methods based on long-coding RNAs and…”
Get full text
Journal Article -
8
Identification of BMVC-8C3O as a novel Pks13 inhibitor with anti-tuberculosis activity
Published in Tuberculosis (Edinburgh, Scotland) (01-01-2025)“…Given the increasing prevalence of drug-resistant tuberculosis (TB), there is an urgent demand in developing novel anti-TB medications with highly effective,…”
Get full text
Journal Article -
9
Design, Synthesis, and Evaluation of the Antitubercular Activity of 5-Phenyl Substituted-5, 6-dihydropyrido[2, 3- d ]pyrimidine-4, 7( 3H , 8H )-dione Compounds
Published in Journal of medicinal chemistry (12-09-2024)“…Tuberculosis (TB) remains a major public health challenge, with research on new anti-TB drugs crucial for global TB elimination efforts. Here, we report a…”
Get full text
Journal Article -
10
Design, Synthesis, and Evaluation of the Antitubercular Activity of 5-Phenyl Substituted-5, 6-dihydropyrido2, 3-dpyrimidine-4, 7(3H, 8H)-dione Compounds
Published in Journal of medicinal chemistry (12-09-2024)“…Tuberculosis (TB) remains a major public health challenge, with research on new anti-TB drugs crucial for global TB elimination efforts. Here, we report a…”
Get full text
Journal Article -
11
IMB-SD62, a triazolothiadiazoles derivative with promising action against tuberculosis
Published in Tuberculosis (Edinburgh, Scotland) (01-09-2018)“…One lead 3,6-disubstituted 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole was identified as an inhibitor of shikimate dehydrogenase with antitubercular activity…”
Get full text
Journal Article -
12
Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads
Published in Bioorganic chemistry (01-09-2021)“…[Display omitted] •Novel Pks13 inhibitor chemotype was identified.•Compounds 1 and 6e exhibited good activity against TB.•The findings facilitate further TB…”
Get full text
Journal Article -
13
Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis
Published in Tuberculosis (Edinburgh, Scotland) (01-03-2016)“…Summary Objective Screen and identify novel inhibitors of isocitrate lyase (ICL) as potent antitubercular agents against Mycobacterium tuberculosis and…”
Get full text
Journal Article -
14
Identification and validation of a novel lead compound targeting 4-diphosphocytidyl-2-C-methylerythritol synthetase (IspD) of mycobacteria
Published in European journal of pharmacology (05-11-2012)“…Tuberculosis is a serious threat to world-wide public health usually caused in humans by Mycobacterium tuberculosis (M. tuberculosis). It exclusively utilizes…”
Get full text
Journal Article -
15
Construction of small plasmid vectors for use in genetic improvement of the extremely acidophilic Acidithiobacillus caldus
Published in Microbiological research (01-10-2013)“…The genetic improvement of biomining bacteria including Acidithiobacillus caldus could facilitate the bioleaching process of sulfur-containing minerals…”
Get full text
Journal Article